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There is considerable  evidence from a  variety of sources  to indicate that the im- 
mune response is under some form of genetic control (1-13). Most previous attempts 
to demonstrate genetic control of the antibody response have succeeded only in show- 
ing a definite  correlation between the quantitative response of parents and offspring, 
without  any clearcut pattern of inheritance  (2, 3, 5, 7). The only exception  to this 
statement is the finding  by Levine, Ojeda, and Benacerraf (9, 10,  12)  that  the  re- 
sponse of guinea pigs to any of four different hapten-poly-L-lysine conjugates appears 
to be genetically transmitted as a  unigenie  Mendelian dominant trait, the homozy- 
gous recessive  animals being unable to respond to any of the four conjugates tested. 
While  the precise nature of this qualitative genetic control remains unknown  (11), 
the specificity of the genetic difference for the poly-T.-lysine "carrier" and not for the 
hapten determinant, has led the authors to conclude  that this control is exercised  at 
some point prior to the actual induction  of antibody formation. Up to the present 
time, it has not been possible  to demonstrate genetic control of the production of 
antibody directed  against a  particular antigenic determinant  or group of determi- 
nants. 
The present studies were begun following the chance observation, in animals 
immunized  by Dr.  John  Humphrey, of a  marked  quantitative  difference be- 
tween  two  strains  of rabbits  (Sandylops  and  Himalayans)  in  their  antibody 
response to a  branched, mulfichain synthetic polypeptide, poly(tyr,glu)-poly- 
DL-ala--polylys,  (T,G)-A--L.  This  finding  stimulated  a  search  for  a  similar 
difference in antibody response between strains of inbred mice, and led to the 
discovery that  CBA  and  C57  mice also differ markedly in  their  antibody re- 
sponse to (T, G)-A--L. The results indicate that this difference is about tenfold 
in  magnitude,  genetically determined,  and  specific for the  antigenic  determi- 
nant.  The  genetic  disparity  underlying  this  difference  in  antibody  response 
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appears to consist of a single major genetic factor, with perhaps one or more 
modifying factors whose quantitative contribution is minor. 
Materials and Methods 
Antigens.--Most  of  the  studies were  carried out using  (T,G)-A--L  509  as  the antigen. 
This polypeptide is synthesized in three steps, and consists of a poly-L-lysine backbone, with 
side chains of poly-DL-alanine built on the  ~-amino groups of lysine. The amino termini of 
these poly-nL-alanine side chains are then covered with peptides containing both L-tyrosine 
and L-ghitamic acid. The general plan of this antigen is shown in Fig.  1. The residue molar 
ratio in the polymer 509 was lys:tyr:glu:DL-ala as  1:2.14:4.1:19.6.  Its average molecular 
weight, 232,000,  was calculated from an intrinsic sedimentation coefficient, s20w =  7.5S,  an 
intrinsic diffusion coefficient, D~0w =  2.5 X  10  -7 cm2/second, and a partial specific volume, 
l  l  ,"  ! 
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FIG. 1.  A schematic diagram of the structural pattern of (T,G)-A--L 509. 
=  0.685. The sedimentation and diffusion coefficients were measured in 0.1  M phosphate 
buffer pH  7.0,  in a  Spinco model E  ultracentrifuge, as described by Sela eta/.  (18). These 
figures correspond to an average of 100 lysine residues in the polylysine backbone; 17 alanine 
residues in each side chain; and  1 tyrosine and 2  glutamic residues on the tip of each side 
chain. This sample was prepared and characterized by Dr. Israel Schechter. 
(H, G)-A--L 220 is a  synthetic polypeptide built on the same general pattern as  (T, G)- 
A--L, but with L-histidine substituted for tyrosine. The residue molar ratio in polymer 220 
was lys:his:glu:I)L-ala as 1:1.10:3.7:18.8, and its average molecular weight is 40,000. 
Animals.--CBA and C57 black mice were those available at the National Institute for 
Medical Research, Mill Hill. These strains had been maintained at the Institute for a number 
of years. All other strain combinations were bred from these two strains. 
Immunization.--Considerable  effort was spent in determining the route and mode of im- 
munization which was most effective.  (T, G)-A--L 509 proved to  be non-antigenic if given 
in 0.15 N NaC1, pH 7.0 (saline) or adsorbed on alum, weakly antigenic when given in incom- 
plete Freund's adjuvant, and moderately antigenic in complete Freund's adjuvant. Foot-pad 
injections gave  titers slightly higher  than  the intraperitoneal or  intramuscular route.  Ac- 
cordingly, mice were immunized with 1,  10, or 100 #g of antigen in complete Freund's adju- 
vant (1 part antigen: 1 part lanolin: 2 parts liquid paraffin, with 4 mg Mycobacterium tubercu- 
losis per ml) distributed in the two hind foot-pads, followed 5 weeks later by an identical 
injection of the antigen in saline. All mice were bled from the tail vein on the 10th day after 
the booster injection. H-UGH O. MCDEVITT AND  MICHAEL  SELA  519 
Serum Antibody  Determinations.--All sera were titered individually. Ten #1 of mouse anti- 
serum was incubated with 1.6/zg of (T,G)-A--L 509 trace labeled with 112s by the method 
of McFarlane (14),  or with 0.14 to 0.20 #g of (H,G)-A--L 220 trace labeled with I m  by the 
method  of  Greenwood, Hunter,  and  Glover  (15), or with 20 /zg of  bovine serum  albumin 
(BSA)  (Armour Pharmaceutical  Company,  Kankakee,  Illinois),  labeled  with I lal  by  the 
method of McFarlane (14), in a  volume of 0.5 to 0.75 ml for 1 hour at 37°C. Then, an excess 
of rabbit anti-mouse "},-globulin antiserum was added in an amount  sufficient to precipitate 
all the mouse antibody present. After overnight incubation at 4°C, the precipitates were centri- 
I00 
90 
12)  8O 
o  Cc  60 
Z  ~J 
~  50 
o  V- 
nn  Z 
Z  <I  40 
LU 
.... I}o. 
I 
I  i 
16  3.2 
I  I  I  I  I  I 
~8  6.4  8.0  9.6  11.2  12.8 
p.g  ANTIGEN  ADDED 
FIG. 2.  Alternative methods of comparing various mouse antisera with respect to antigen- 
binding capacity; (a) comparison of "per cent antigen bound" at a fixed amount of antigen/ 
volume  mouse  antiserum  (vertical dotted  line),  and  (b)  comparison  of  "amount  antigen 
bound"  (per cent X  total antigen) at a  fixed per cent antigen bound of 30 per cent  (hori- 
zontal dotted line). On  the latter basis, 3  CBA's bind about 32 #g antigen/ml antiserum, 
and two C57's bind about 340 to 380 #g antigen/ml antiserum. 
fuged, washed once, and the radioactivity in precipitate and supernatant counted in a  well- 
type scintillation counter. Results were expressed as "per cent antigen bound", i.e. the percent- 
age of 1.6 #g of  (T,G)-A-L 509 bound by i0/~1 of mouse antiserum. Ideally, sera should be 
compared in terms of antigen-binding  capacity at a fixed value for per cent antigen bound, such 
as 30 per cent. However, this requires a series of determinations on each serum, and a  large 
volume of rabbit anti-mouse "y-globulin.  The alternative method of comparing per cent anti- 
gen bound at a  fixed amount of antigen/volume mouse antiserum is more economical, and 
only has the effect of minimizing differences between various sera, as can be seen in Fig. 2. 
Normal mouse serum (either CBA, C57, or F1) usually binds only 1 to 2 per cent in this sys- 
tem, and never more than 5 per cent. The iodinated antigen is 96 per cent precipitable by 
specific antibody. 
The rabbit anti-mouse "y-globulin  used in these experiments was obtained by immunizing 
rabbits with a  partially purified 7S T~ mouse myeloma protein (MP 5563). This antiserum 520  GENETIC CONTROL  OF THE ANTIBODY RESPONSE 
reacted with purified mouse Bence-Jones protein,  7S "/1-globulin, 7S 7rglobulin,  and  /$2a 
(IgA) globulin indicating that the antiserum reacted with determinants common to most, 
if not all, mouse immunoglobulins. In addition, identical values for per cent antigen bound 
were obtained using this antiserum or a polyvalent antiserum reacting with the four major 
classes of immunoglobulins: 7S 71,  7S 7% fl~a (IgA), and 7IM  (IgM)  (16). These studies 
characterizing the rabbit anti-mouse T-globulin were performed with the very kind collabora- 
tion of Dr. John L. Fahey. 
RESULTS 
Preliminary experiments employing CBA, C57, CBA X  C57  F1, F1 X  CBA, 
and  F1  X  C57  mice  (65  animals)  gave strong indications  of a  genetic factor 
responsible for the large and consistent difference in antibody response between 
the two parent strains of mice. These experiments were then repeated at vary- 
ing doses of antigen, and in larger numbers of animals. 
(a)  Immunization with  10 #g (T,G)-A--L 509 in Freund's adjuvant and 10 
/zg in saline. 
These results are shown in Fig. 3, where the number of animals falling in a 
given percentile of "per cent antigen bound" is plotted for the various strains 
and  strain  combinations.  CBA's  give  a  very poor  response  to  this  antigen, 
while C57's are much stronger responders. Individual titrafions of C57 antisera 
have  shown  that  their  antigen-binding  capacity  at  comparable levels  of per 
cent antigen bound is tenfold or more greater than the antigen-binding capacity 
of  CBA  antisera.  The  most  striking  points  are  the  uniformity  of  response 
within the  CBA or C57  strains;  the large difference between the strains;  and 
the lack of any overlap. The CBA X  C57  F1 nlice give a response intermediate 
between  the  parental  strains  and  slightly  overlapping  the  C57  strain.  F1  X 
CBA back-cross mice all fall in the range encompassed by the F~ or the CBA 
mice while F~ X  C57 back-cross mice all fall within the range encompassed by 
the  F1  or  C57  mice. Again,  there is  a  striking  absence of overlap. Antibody 
response was not linked  to sex or coat color. To rule out the possibility that 
these  differences  reflected  different  points  on  a  dose-response curve,  further 
immunization studies were done. 
(b)  Immunization with  1/~g (T, G)-A--L 509 in Freund's adjuvant and 1 #g 
in saline. 
These results are plotted in Fig. 4. It is immediately apparent that this dose 
of antigen is submaximal in both CBA and C57 mice. In both strains the ani- 
mals  either  show  no  detectable  response  or  a  very low  response,  and  both 
strains are below their average response to 10/zg of antigen. 
(c)  Immunization with 100/zg of (T, G)-A--L 509 in Freund's adjuvant and 
100 ~g in saline. 
These results are plotted in Fig. 5. In general, there is slightly greater vari- 
ability  than  with  the  10 #g dose,  but  the  overall pattern remains the  same. 
The exception to this  is the  lower response of the  C57  mice. The reason for 8- 
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FI6. 3.  Immune response of mice given 10 gg (T, G)-A--L 509 in complete Freund's adju- 
vant, and boosted with 10 ~tg of the same antigen in saline. 
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this is not clear. However, prior to boosting, the 100/~g C57 mice have a higher 
titer than the 10/~g C57 mice, and their lower response to boosting apparently 
indicates that 100 gg of antigen in saline is an overdose, for reasons which are 
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FIG. 4.  Immune response of mice given 1 ~tg (T,G)-A--L 509 in complete Freund's adju- 
vant, and boosted with 1 #g of the same antigen in saline. 
as yet unknown.  The fact remains that a  tenfold increase in dose of antigen 
does not abolish the strain differences in response which are seen with a  10 ttg 
dose. 
The  possibility  remains  that  this  disparity  in  antibody  response  reflects 
some non-specific factor  such  as nutrition,  environmental effect,  or  age.  An 
the mice used were of the same age (2 to 3 months at the start of immuniza- HUGH  O.  MCDEVITT  AND  MICHAEL  SELA  523 
tion), both sexes (in equal numbers) and were handled in an identical manner. 
In addition, breeding of the F1 and back-cross combinations necessitated mix- 
ing the strains, so that their bacterial flora were presumably similar. 
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FIO. S.  Immune response of mice given 100  /~g of (T,G)-A-L 509 in complete Freund's 
adjuvant, and boosted with 100  #g of the same antigen in saline. 
It is also possible that the observed differences in immlme response reflect 
some general difference in immunologic reactivity, such as a difference in total 
number of lymphoid cells, or in ability to synthesize antibody of any specificity. 
This possibility was tested next. 524  GENETIC CONTROL  OF THE ANTIBODY RESPONSE 
(d)  Immunization  with  100/~g  bovine  serum  albumin  (BSA)  in  Freund's 
adjuvant and 100 ;zg in saline. 
Animals were injected  in  the  same manner  and  on the  same time  scale  as 
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Fro. 6. Immune response of mice given 100/~g bovine serum albumin (BSA) in complete 
Freund's adjuvant and boosted with 100 #g of the same antigen in saline. In this series, all 
titrations were done with 20/zg B SA-I  TM per 10 pl antiserum, and the two strains bind approxi- 
mately 800 #g BSA/ml antiserum. 
for the experiments already described. The results are shown in Fig. 6. In both 
strains  of mice,  the response  to BSA shows a  greater  variability  than  the re- 
sponse  to  (T,G)-A--L,  but  the  scatter  and  the  averages  for  the  two  strains 
are  remarkably  similar.  In  addition,  it  should  be  noted  that  the  results  are 
virtually unchanged by the use of 50 per cent saturated  (NI-t4)2SO4 to precipi- 
tate  the  BSA-anti-BSA complexes,  in place  of rabbit  anti-mouse ~/-globulin. 
This finding constitutes further evidence that the rabbit anti-mouse ~,-globulin HUGH  O. MCDEVITT AND  MICHAEL SELA  525 
used throughout this study was not selectively precipitating only a particular 
fraction of the total mouse-~-globulin present in each antiserum. 
On the evidence presented up to this point, it seems reasonable to assume 
that  the  quantitative  difference in  the  amount of  anti-(T,G)-A--L  binding 
capacity produced in CBA and C57 mice is under genetic control. The nature 
of this genetic control is of course unknown, but the first step in analyzing it 
must be an estimate of the number of genetic factors differing between the two 
strains. An attempt to do this was made by testing larger numbers of the two 
back-cross strains. On the basis of the previous experiments, a per cent antigen 
bound value of 0 to 30 per cent was arbitrarily designated the CBA phenotype, 
a  per  cent antigen bound value of 30  to  70 per  cent was designated the FI 
phenotype, and a value of 70 to 100 per cent was designated the C57 pheno- 
type. If the observed differences were the result of a single genetic factor, then 
in a  large number of F1  X  CBA mice, half should have  the  FI phenotype, 
half the  CBA phenotype and none the C57 phenotype. The F1  X  C57  mice 
should give a similar bimodal distribution. The results of testing 48 F1 X  CBA 
mice and 54 F1 X C57 mice with 10 ~g (T, G)-A--L 509 are shown in Figs. 7 and 8. 
In both back-cross combinations, almost all the mice fall in one of the two pheno- 
type ranges. (The lack of a clear bimodal distribution could be a  reflection of 
imprecision in the assay method and of the slight overlap between the FI and 
parental strains.) However, in both back-cross strains, 4 mice fall outside the 
predicted limits; i.e., 4 members of the F1 X  CBA strain fall in the C57  range, 
and 4 members of the F1 X  C57 strain fall in the CBA range. In addition, the 
F1 X  C57 strain deviates considerably from a fifty-fifty  distribution. Although 
this could conceivably  be attributed to statistical variation, this degree of varia- 
tion was not encountered in 83 CBA, 89 C57,  or over 100 F~ mice. While the 
predominantly bimodal distribution is compatible with a single genetic factor, 
the presence of a few animals outside the predicted limits makes equally reason- 
able the tentative assumption that this genetic difference involves one major 
factor and an unknown number of modifying factors whose quantitative effect 
is slight. A choice between this alternative and that of a single genetic factor 
is not possible on the basis of the evidence to date. 
For reasons which will be discussed more fully below, it appears very likely 
that the antigenic determinants on (T, G)-A--L are restricted to the tyrosine 
and  glutamic  acid  residues  which  make  up  the  amino-terminal tips  of  the 
multiple side chains of the molecule. This makes it possible to test whether 
the genetic difference in response to (T,G)-A--L in CBA and C57  mice is a 
function of the type of antigenic determinant on the molecule, or a function of 
the A--L "carrier" portion of the  (T,G)-A--L.  CBA and C57 mice were im- 
munized with  either  10  /zg  or  100  /~g of poly(his,glu)-poly DL-ala--polylys, 
(H, G)-A--L 220, emulsified in complete Freund's adjuvant, and boosted with 
a similar dose of the antigen in saline. The route and time scale of immuniza- 
tion and bleeding were identical to those used with (T, G)-A--L 509. Anfisera 526  GENETIC CONTROL  OF THE ANTIBODY RESPONSE 
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FIG.  7.  Immune response of Fz  X  CBA mice given 10/~g  (T,G)-A-L 509 in complete 
Freund's adjuvant, and boosted with 10/zg of the same antigen in saline. 
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were titered with 0.2 pg (H, G)-A--L  220-1181 per 10 #1 antiserum,  to compen- 
sate for the fact that the molecular weight of (H, G)-A--L 220 is 40,000, versus 
230,000 for  (T, G)-A--L 509. The results of a  typical experiment are seen  in 
Fig. 9. At both dosage levels,  CBA mice quite uniformly respond to (H, G)- 
A--L,  while  C57 mice give no detectable response.  Thus, putting histidine in 
place of tyrosine in  the  (T,G)-A--L  molecule  completely reverses the usual 
quantitative  difference  in response  to  (T,G)-A--L seen in  CBA's and  C57's. 
From this fact, it appears that  the genetic difference  between CBA and  C57 
mice in their  response  to  (T,G)-A--L is specific for the  (T,G)  antigenic  de- 
terminant. 
DISCUSSION 
Genetic factors of the sort described here have not usually been found even 
when sought (7). Often, the finding is that noted by Bumet (17) and also found 
in this study when BSA was the antigen used, namely, a scatter in antibody 
titer in inbred strains. However, Ipsen (6) has shown that inbred mouse strains 
differ by as much as tenfold in the amount of tetanus toxoid required to elicit 
an  equal  degree  of  immunity  to  challenge  with  tetanus  toxin.  In  addition, 
Dineen  (13)  has  shown that,  in immunizing  different inbred strains  of mice 
with sheep red blood cells,  the variation between the strains  is considerably 
greater than the variation within a strain,  suggesting  that the interstrain  dif- 
ferences were of genetic origin.  Studies of this  type were carried further  by 
Stern,  Brown, and Davidsohn  (5),  who demonstrated  a  genetic difference  in 
the ability of C3H and C57BL mice to produce natural agglutinins  for sheep 
erythrocytes.  These  authors  studied  the  corresponding  F1  and  back-cross 
strains, with results similar to those presented in this study. Marked differences 
in response to pneumococcal polysaccharide in five strains of inbred mice were 
also found by Fink and Quinn  (4).  Finally, Arquilla  and  Finn  (8) have pre- 
sented detailed evidence using inbred guinea pigs that antibodies to different 
antigenic  determinants  on  the  insulln  molecule  are  under  genetic  control. 
These results,  taken with  those of Levine a  a2.  (9-12),  lend  support  to  the 
idea that the process of antibody formation is under direct genetic control. 
One possible reason for the lack of interstrain differences  and the scatter in 
response to complex antigens  such  as BSA may lie  in  their  complexity, the 
response to BSA being the sum of several separate responses to all the various 
antigenic  determinants  on  the  BSA molecule  (see  also reference  7).  (T, G)- 
A--L,  on  the  other  hand,  is  a  molecule  of  restricted  antigenic  specificity. 
Branched,  multi-poly-DL-alanyl-poly-L-lysine  (A--L)  is non-antigenic  in  rab- 
bits  (18),  and branched muld-(poly-L-glutamyl)-poly-DL-alanyl-poly-L-lysine, 
(G-A--L),  (i.e. (T,G)-A--L without the tyrosine)  is non-antigenic  in rabbits 
(18) and virtually non-antigenic in mice (19). Fuchs and Sela (20) have shown 
in rabbits that tyrosine is a prominent part of the antigenic site in (T, G)-A--L. 528  GENETIC CONTROL OF THE ANTIBODY RESPONSE 
These  authors  found  that  even  a  large  excess  of  mutli-(poly-L-glutamyl)- 
poly-DL-alanyI-poly-L-lysine,  (G-A--L), did not inhibit  the  reaction between 
(T, G)-A--L, and rabbit anti-(T, G)-A--L, whereas  several  linear  or branched 
polymers containing both  tyrosine and glutamic acid were extremely effective 
inhibitors. Thus,  it is probable that in mice as well as in rabbits,  (T,G)-A--L 
is an  antigen  of restricted specificity, the  antigenic sites all being some  corn- 
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FIG. 9.  Immune response of mice given  I0 #g or 100  #g  (H, G)-A--L 220  in complete 
Freund's adjuvant, and boosted with 10 /zg or 100 #g of the same antigen in saline. In this 
series, all titrations were done with 0.2 #g (H, G)-A--L 1181 per I0 #l of antiserum to com- 
pensate for the relatively low molecular weight  (40,000) of this antigen. HUGH  O. MCDEVITT AND  MICHAEL SELA  529 
bination of tyrosine, glutamic acid, and, to a much smaller extent, alanine. A 
second factor permitting demonstration of a strain difference in response may 
lie in the use of a maximal antigenic stimulus. 
The fact that the antigenic sites on (T,G)-A--L are some combination of 
tyrosine and glutamic acid makes even more striking the  demonstration that 
(H,G)-A--L 220 is non-antigenic in C57  mice and  antigenic in CBA mice, a 
result  almost opposite  to  that  obtained with  (T,G)-A--L.  These  results  are 
summarized in Fig.  10. Thus, substituting histidine for  tyrosine in the anti- 
genic site of two molecules of the same general pattern of construction com- 
pletely alters  an immune response which has been  shown to  be  genetically 
determined. The exact nature of this genetic control is unknown,  but it ap- 
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Fro. 10.  A summary of the immune response of CBA and C57  mice to two related syn 
thetic polypeptide antigens. The animals were immunized and titered in the same way and 
the results are expressed as "per cent antigen bound". 
pears to be due to the nature of the antigenic determinant rather than some 
other portion of the molecule. 
We are dealing then, with the genetic control of the production of antibody 
against a relatively well defined antigenic site, or sites. A precise understanding 
of the mechanism underlying this genetic  difference might be  of great help in 
understanding mechanisms of antibody formation. At the present time, it is 
only possible to draw broad inferences, primarily as a guide to further experi- 
ments. 
It seems unlikely that we are dealing with a genetic factor (or factors) which 
exerts its effect prior to the actual induction of antibody formation, (such as 
an enzyme which degrades the antigen in some specific way) since both CBA 
and C57 mice are capable of responding to (T, G)-A--L. However, it is possible 
that we are in reality studying two separate antibody responses, one of them 
present in both strains, the other totally lacking in the CBA's and present in 
the C57's, where it is produced in much higher titer than the shared response. 
This possibility is susceptible to experimental test. 
It also seems unlikely that the poor response of CBA mice can be explained 
on the basis of an antigenic determinant found on (T, G)-A--L and also present 
in  the  "self" antigens of the  CBA strain,  thus rendering  CBA's tolerant to 530  GENETIC CONTROL  0]~ THE ANTIBODY RESPONSE 
this determinant (see reference (21)).  Were this the case,  the CBA X  C57  F1 
mice should also possess  this determinant, and respond in a manner similar to 
the CBA parental strain. 
It should be pointed out here that the titering system used in these experi- 
ments  only  reflects  antigen-binding  capacity,  and  cannot  measure  actual 
amounts of antibody protein present. (Typical precipitin curves have, however, 
been obtained using pooled CBA X  C57  F1 sera.)  It is possible that, for ex- 
ample,  CBA mice manufacture as much  antibody protein  as  C57  mice, but 
with a much lower energy of binding for (T, G)-A--L. While our titering system 
is ill-adapted to testing this idea, it should be possible  to do so using small 
peptides  of  tyrosine and glutamic acid.  Also,  a  carefu~ comparison of  CBA 
anti-(T,G)-A--L,  CBA anti-(H,G)-A--L, and  C57  anti-(T,G)-A--L, with re- 
spect to their structure and to their relative abilities to bind either antigen or 
both antigens together, might reveal similarities or differences between these 
three  antibody populations,  and perhaps  shed  some light on why these two 
antigens elicit such different patterns of response in the two strains of mice. 
Finally, the intermediate response of the CBA X  C57 171 mice is suggestive 
of a gene-dose effect in the heterozygote, and might lead one to infer the pres- 
ence of a structural difference in some as yet unidentified protein, a protein in 
some way responsible for the recognition of the antigen, or the antibody itself. 
Note  Added  in  Proof.--Since this paper was prepared for publication,  the findings 
of Pinchuck and Maurer have become available  (Fed.  Proc.,  1965, 9.4, 184). These 
authors have shown that the ability of mice to respond  to a linear,  synthetic poly- 
peptide, poly (glusT,  lys~, alas), appears to be inherited  as a simple Mendelian domi- 
nant. These results, which are similar to those of Levine et al.  (9-12) provide  addi- 
tional evidence that the immune response is under direct genetic control. 
SU'MM%RY 
Immunization of CBA and C57 mice with a branched, multichain synthetic 
polypeptide, poly (tyr,glu)-poly DL-ala--poly lys,  ((T,G)-A--L), in  Freund's 
complete adjuvant results in a tenfold or more difference in the antigen-binding 
capacity of sera from the two strains, although they respond equally to bovine 
serum albumin. Immunization of CBA X  C57 Fx, F1 X  CBA, and F1 X  C57 
mice reveals definite genetic control of the response to (T, G)-A--L, which ap- 
pears  to be  due to  a  single major genetic factor, with perhaps  one or more 
modifying factors. Immt,  nlzation of CBA and C57  mice with (H,G)-A--L, a 
synthetic polypeptide in which histidine replaces tyrosine, gives the opposite 
result, CBA's respond and C57's do not. From this, it appears that the genetic 
control of the response to (T, G)-A--L is specific for the antigenic determinant. 
The implications of these results are discussed. 
We would like to acknowledge with pleasure the encouragement, support, and advice of 
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